[09/21/17]
Posted on September 21, 2017 in False Claims Act Defense
Published by: Hall Render
The Tenth Circuit’s recent decision in United States ex rel. Little v. Triumph Gear Sys., Inc. refines its definition of “intervene” in light of the Supreme Court’s decision in United States ex rel. Eisenstein v. City of New York. In doing so, the Tenth Circuit also seems to indicate that the original filing by... READ MORE
Tags: Case Analysis, FCA, Little, Triumph
[06/30/16]
Posted on June 30, 2016 in False Claims Act Defense
Written by: David B. Honig
In November 2015, the Bipartisan Budget Act of 2015 went into effect. One aspect of that act was the Federal Civil Penalties Inflation Adjustment Act Improvements Act of 2015. The new law required that the Program Fraud Civil Remedies Act and the False Claims Act (“FCA”) penalties be “corrected” to adjust for inflation since... READ MORE
Tags: adjustment, Case Analysis, Damages, Department of Justice, False Claims Act, FCA, fines, government, inflation, maximum, minimum, penalties, Statutes and Regulations
[06/16/16]
Posted on June 16, 2016 in False Claims Act Defense
Written by: David B. Honig
The U.S. Supreme Court issued its decision today in Universal Health Services, Inc. v. United States ex rel. Escobar, and it will have an enormous effect on False Claims Act (“FCA”) cases throughout the nation. In Escobar, the FCA case was based upon the theory that counseling was provided by practitioners who were not properly... READ MORE
Tags: Case Analysis, Escobar, false certification, Implied False Certification, United States Supreme Court, Universal Health Services, USSC
[05/31/16]
Posted on May 31, 2016 in False Claims Act Defense
Written by: David B. Honig
A recent whistleblower case could have a significant impact on Medicare Part D charge limits and corresponding reimbursement and could have ripple effects for aspects of other Medicare programs. The Seventh Circuit Court of Appeals ruled that reduced prescription prices offered by a large retail pharmacy (here Kmart) to participants enrolled in a popular discount... READ MORE
Tags: Case Analysis, False Claims Act, FCA, Garbe, Kmart, materiality, pharmacy, pricing, usual and customary
[05/30/16]
Posted on May 30, 2016 in False Claims Act Defense
Written by: David B. Honig
Releases of FCA claims my only be effective in very limited circumstances, the Second Circuit Court of Appeals ruled in a decision this week. In US ex rel. Ladas v. Exelis, Inc, et al., the court ruled that a pre-filing release is unenforceable as a matter of public policy – the encouragement of qui... READ MORE
Tags: Case Analysis, Employment, Exelis, False Claims Act, FCA, Lados, Release, Second Circuit, Settlement
[03/02/15]
Posted on March 2, 2015 in Health Law News
Written by: Drew B. Howk
The Third Circuit Court of Appeals¹ became the third federal appeals court in one week to issue an opinion regarding the False Claims Act’s Public Disclosure Bar.² In a non-precedential opinion, the Third Circuit affirmed the dismissal of a pharmacist’s allegations finding the allegations were based on public information for which the Relator was not... READ MORE
Tags: Case Analysis, Fifth Circuit, New Jersey, original source, Pennsylvania, public disclosure bar, sixth Circuit, Third Circuit
[06/28/14]
Posted on June 28, 2014 in False Claims Act Defense, Health Law News
Written by: Drew B. Howk
Yesterday, the D.C. Circuit issued a much-anticipated decision regarding whether or not internal compliance investigations were privileged. Two recent lower court decisions had ruled that such compliance investigations were not privileged because they were for business rather than legal purposes. The D.C. Circuit disagreed and found that such compliance investigations are for legal purposes... READ MORE
Tags: Case Analysis, compliance, Discovery, Privilege